These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10455466)

  • 1. The impact of pharmacotherapy on weight management in type 2 diabetes.
    Hauner H
    Int J Obes Relat Metab Disord; 1999 Jun; 23 Suppl 7():S12-7. PubMed ID: 10455466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.
    Scheen AJ; Ernest P
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity medications and the treatment of type 2 diabetes.
    Greenway F
    Diabetes Technol Ther; 1999; 1(3):277-87. PubMed ID: 11475274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and type 2 diabetes: a conflict of interests?
    Williams G
    Int J Obes Relat Metab Disord; 1999 Jun; 23 Suppl 7():S2-4. PubMed ID: 10455464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of diabetes in patients with severe obesity.
    Scheen AJ
    Biomed Pharmacother; 2000 Mar; 54(2):74-9. PubMed ID: 10759290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing type 2 diabetes mellitus in patients with obesity.
    Hauner H
    Treat Endocrinol; 2004; 3(4):223-32. PubMed ID: 16026105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiobesity pharmacotherapy in the management of type 2 diabetes.
    Scheen AJ; Lefèbvre PJ
    Diabetes Metab Res Rev; 2000; 16(2):114-24. PubMed ID: 10751751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes.
    Scheen AJ; Van Gaal LF
    Lancet Diabetes Endocrinol; 2014 Nov; 2(11):911-22. PubMed ID: 24731666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of obese diabetics.
    Svacina S
    Adv Exp Med Biol; 2012; 771():459-64. PubMed ID: 23393696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.
    Miles JM; Leiter L; Hollander P; Wadden T; Anderson JW; Doyle M; Foreyt J; Aronne L; Klein S
    Diabetes Care; 2002 Jul; 25(7):1123-8. PubMed ID: 12087008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of orlistat in overweight and obese patients with type 2 diabetes mellitus.
    Maetzel A; Ruof J; Covington M; Wolf A
    Pharmacoeconomics; 2003; 21(7):501-12. PubMed ID: 12696990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes.
    Després JP
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S53-61. PubMed ID: 14502101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of obesity in NIDDM (non-insulin-dependent diabetes mellitus).
    Cheah JS
    Singapore Med J; 1998 Aug; 39(8):380-4. PubMed ID: 9844503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management strategies for coexisting diabetes mellitus and obesity.
    Scheen AJ
    Drugs; 2003; 63(12):1165-84. PubMed ID: 12790691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
    Baretić M; Troskot R
    Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for obesity in menopausal women.
    Samat A; Rahim A; Barnett A
    Menopause Int; 2008 Jun; 14(2):57-62. PubMed ID: 18519266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.